Tokyo, Dec. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059308) titled 'Estimating of the Minimal Important Change of the Action Research Arm Test in Subacute Stroke Patients' on Dec. 10.
Study Type:
Observational
Primary Sponsor:
Institute - Kitasato University
Condition:
Condition - stroke
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to estimate the Minimal Important Change (MIC) of the Action Research Arm Test (ARAT) in subacute stroke patients undergoing inpatient rehabilitation, in accordance with the COSMIN guidelines. By clarifying the MIC, this study seeks to add a patient- and clinician-meaningful perspective to the interpretation of ARAT scores, thereby providing a foundation for more appropriate treatment selection in subacute stroke rehabilitation
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Ptients with upper extremity paresis resulting stroke are included.
(1) age 20 years or older
(2) ability to maintain a sitting position
(3) absence of severe cognitive or higher brain dysfunction
(4) ability to undergo ARAT assessment.
Key exclusion criteria - Patients who score 55 or higher on the ARAT will be excluded.
Target Size - 100
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2023 Year 12 Month 14 Day
Date of IRB - 2023 Year 12 Month 20 Day
Anticipated trial start date - 2024 Year 01 Month 05 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067749
Disclaimer: Curated by HT Syndication.
